Product Images Regadenoson
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Regadenoson NDC 68083-175 by Gland Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
regadenoson-spl-carton - regadenoson spl carton
Regadenoson Injection is a Pharmacologic Stress Agent used for diagnostic purposes only and must be administered only by intravenous use. Each mL of Regadenoson Injection contains 0.08 mg regadenoson, 10.9 mg of dibasic sodium phosphate dihydrate, 5.4 mg monobasic sodium phosphate monohydrate, 150 mg propylene glycol, 1 mg edetate disodium dihydrate and Water for Injection, g.s.. The dosage must be followed as per the package insert, and the solution must be stored at 20° to 25°C (68° to 77°F). The product is manufactured by Gland Pharma Limited in Hyderabad, India. Batch number is not mentioned.*
regadenoson-spl-structure - regadenoson spl structure
regadenoson-spl-vial - regadenoson spl vial
Regadenoson Injection is a pharmacologic stress agent used for diagnostic purposes. It comes in a 5 mL single-dose vial with a concentration of 0.4 mg/5 mL (0.08 mg/mL) and is for intravenous use only. The details on the packaging include a National Drug Code (NDC) of 68083-175-01. The other text is not readable due to being gibberish or containing non-English characters.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
